Lupus erythematosus: systemic and cutaneous manifestations

N Rothfield, RD Sontheimer, M Bernstein - Clinics in dermatology, 2006 - Elsevier
… Author, Naomi Rothfield treats patients with rising anti-DNA levels associated with falling
complement levels with an increased dose of prednisone because of experience with onset of …

The 1982 revised criteria for the classification of systemic lupus erythematosus

…, NF Rothfield, JG Schaller, N Talal… - … : Official Journal of …, 1982 - Wiley Online Library
… Lie TH, Rothfield NF: An evaluation of the preliminary criteria for the diagnosis of systemic
lupus erythematosus. Arthritis Rheum 15532-534, 1972 3. Davis P, Atkins B, Josse RG, …

[HTML][HTML] Cyclophosphamide versus placebo in scleroderma lung disease

…, M Olman, B Fessler, N Rothfield… - … England Journal of …, 2006 - Mass Medical Soc
Background We conducted a double-blind, randomized, placebo-controlled trial to determine
the effects of oral cyclophosphamide on lung function and health-related symptoms in …

Range of antinuclear antibodies in “healthy” individuals

…, RN Maini, JS McDougal, NF Rothfield… - … : Official Journal of …, 1997 - Wiley Online Library
Objective. To determine the range of antinuclear antibodies (ANA) in “healthy” individuals
compared with that in patients with systemic lupus erythematosus (SLE), systemic sclerosis (…

Identification of a family of human centromere proteins using autoimmune sera from patients with scleroderma

WC Earnshaw, N Rothfield - Chromosoma, 1985 - Springer
We have examined “preimmune” serum samples from a patient who progressively developed
the symptoms of scleroderma CREST over a period of several years. During this period, …

Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease

…, N Rothfield, M Metersky, D Khanna, N Li… - American journal of …, 2007 - atsjournals.org
Rationale: The Scleroderma Lung Study enrolled 158 patients with scleroderma-related
interstitial lung disease in a placebo-controlled trial of oral cyclophosphamide (CYC). Although …

Molecular cloning of cDNA for CENP-B, the major human centromere autoantigen

…, DA Kaiser, TD Pollard, NF Rothfield… - The Journal of cell …, 1987 - rupress.org
… Earnshaw, WC, and NF Rothfield. 1985. Identification of a family of human centromere …
Marino, and NF Rothfield. 1986. Three human chromosomal autoantigens are recognized …

Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon

…, ME Csuka, TA Medsger Jr, NF Rothfield… - Arthritis & …, 2002 - Wiley Online Library
Objective To document disease activity and functional status in patients with scleroderma (systemic
sclerosis [SSc]) and Raynaud's phenomenon (RP) and to determine the sensitivity to …

CENP-C, an autoantigen in scleroderma, is a component of the human inner kinetochore plate

…, CA Cooke, H Ratrie III, M Maurer, NF Rothfield… - Cell, 1992 - cell.com
We have isolated and characterized a set of overlap ping cDNA clones that encode the human
centromere autoantigen centromere protein C (CENP-C). The identity of these clones has …

[PDF][PDF] Efficacy and safety of epratuzumab in moderately to severely active systemic lupus erythematosus: results from two phase III randomized, double‐blind, placebo …

…, A Roman‐Miranda, N Rothfield… - Arthritis & …, 2017 - Wiley Online Library
Objective Epratuzumab, a monoclonal antibody that targets CD22, modulates B cell signaling
without substantial reductions in the number of B cells. The aim of this study was to report …